BGX (Blackstone Long-Short Creditome Fund) Research & Development: $0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGX Blackstone Long-Short Credit Income Fund BGX
40 GF Score
Price $10.65
GF Value $7.21
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Blackstone Long-Short Creditome Fund Research & Development?

Blackstone Long-Short Creditome Fund BGX -0.75% 40 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates BGX with a GF Score™ of 40/100 and a GF Value™ of $7.21 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Blackstone Long-Short Creditome Fund's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

Blackstone Long-Short Creditome Fund  (NYSE:BGX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Blackstone Long-Short Creditome Fund Research & Development Related Terms

Blackstone Long-Short Creditome Fund Research & Development Historical Data

* Premium members only.

The historical data trend for Blackstone Long-Short Creditome Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blackstone Long-Short Creditome Fund Research & Development Chart

Blackstone Long-Short Creditome Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Blackstone Long-Short Creditome Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BGX
40GF Score
Blackstone Long-Short Credit Income Fund BGX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Blackstone Long-Short Creditome Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Blackstone Long-Short Creditome Fund (BGX) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Blackstone Long-Short Creditome Fund and its competitors.
Is Blackstone Long-Short Creditome Fund's Research & Development too high?
Blackstone Long-Short Creditome Fund's current Research & Development is $0.00 Mil. Overall, Blackstone Long-Short Creditome Fund has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Blackstone Long-Short Creditome Fund's Research & Development compare to GRX and IHD?
Blackstone Long-Short Creditome Fund's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Blackstone Long-Short Creditome Fund and its competitors. Blackstone Long-Short Creditome Fund's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackstone Long-Short Creditome Fund stock overvalued right now?
Based on GuruFocus' analysis, Blackstone Long-Short Creditome Fund (BGX) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.21, compared to a current price of $10.65 — trading 47.7% above its estimated fair value. The current Research & Development is $0.00 Mil. Blackstone Long-Short Creditome Fund's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Blackstone Long-Short Creditome Fund (BGX), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Blackstone Long-Short Creditome Fund (BGX) Overvalued in 2026?

Based on GuruFocus' analysis, Blackstone Long-Short Creditome Fund stock appears to be overvalued. The current stock price of $10.65 is trading 47.7% above its estimated GF Value™ of $7.21. GuruFocus considers Blackstone Long-Short Creditome Fund to be Significantly Overvalued.

Key valuation signals for BGX:

  • Research & Development: $0.00 Mil
  • GF Value™: $7.21 vs. price of $10.65 (47.7% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the BGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blackstone Long-Short Creditome Fund Business Description

Address 345 Park Avenue, 31st Floor, New York, NY, USA, 10154
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.
40GF Score

Get the complete analysis for BGX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.65
Price
$7.21
GF Value